Tenax Therapeutics (TENX) Accumulated Depreciation (2015 - 2021)
Tenax Therapeutics (TENX) posted quarterly Accumulated Depreciation of $60843.0 for Q2 2021, little changed year-over-year from $60905.0 in Q2 2020, and up 1.48% on a QoQ basis from $59953.0 in Q1 2021.
Tenax Therapeutics (TENX) Accumulated Depreciation (2015 - 2021) Analysis & Trends
Tenax Therapeutics has reported Accumulated Depreciation for 5 years, with the latest figure at $60843.0 in Q2 2021.
- Accumulated Depreciation for Q2 2021 came in at $60843.0, changed 0.1% year-over-year; the trailing twelve-month figure through Jun 2021 was $60843.0 (changed 0.1% YoY), and the FY2020 annual result was $60368.0, down 70.45% from the prior year.
- Accumulated Depreciation grew to $60843.0 in Q2 2021, from $59953.0 in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $573121.0 in Q4 2018 and troughed at $59389.0 in Q3 2020.
- A 4-year average of $161658.2 and a median of $74785.0 in 2020 frame the typical range for Accumulated Depreciation.
- The widest annual swing landed in 2020, when Accumulated Depreciation tumbled 70.74%; it then decreased 0.1% in 2021.
- A 4-year view of Accumulated Depreciation shows it stood at $573121.0 in 2018, then sank by 64.35% to $204302.0 in 2019, then slumped by 70.45% to $60368.0 in 2020, then grew by 0.79% to $60843.0 in 2021.
- Per Business Quant data, the three most recent Accumulated Depreciation figures were $60843.0 in Q2 2021, $59953.0 in Q1 2021, and $60368.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 60,843.00 |
| Mar 31, 2021 | 59,953.00 |
| Dec 31, 2020 | 60,368.00 |
| Sep 30, 2020 | 59,389.00 |
| Jun 30, 2020 | 60,905.00 |
| Mar 31, 2020 | 74,785.00 |
| Dec 31, 2019 | 204,302.00 |
| Sep 30, 2019 | 202,993.00 |
| Jun 30, 2019 | 201,684.00 |
| Mar 31, 2019 | 219,897.00 |
| Dec 31, 2018 | 573,121.00 |
| Dec 31, 2015 | 748,604.00 |
| Apr 30, 2015 | 717,379.00 |